Cell surface targeting of μ-δ opioid receptor heterodimers by RTP4
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
μ opioid receptors are G protein–coupled receptors that mediate the pain-relieving effects of clinically used analgesics, such as morphine. Accumulating evidence shows that μ-δ opioid heterodimers have a pharmacologic profile distinct from those of the μ or δ homodimers. Because the heterodimers exhibit distinct signaling properties, the protein and mechanism regulating their levels have significant effects on morphine-mediated physiology. We report the characterization of RTP4, a Golgi chaperone, as a regulator of the levels of heterodimers at the cell surface. We show that the association with RTP4 protects μ-δ receptors from ubiquitination and degradation. This leads to increases in surface heterodimer levels, thereby affecting signaling. Thus, the oligomeric organization of opioid receptors is controlled by RTP4, and this governs their membrane targeting and functional activity. This work is the first report of the identification of a chaperone involved in the regulation of the biogenesis of a family A GPCR heterodimer. The identification of such factors as RTP4 controlling dimerization will provide insight into the regulation of heterodimers in vivo. This has implications in the modulation of pharmacology of their endogenous ligands, and in the development of drugs with specific therapeutic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rtp4 (Receptor transporter protein 4) is a chaperone protein involved in folding G protein coupled receptors (Decaillot et al., 2008).”
From Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens (2018) · cites this paper as Decaillot et al., 2008
In the citing paper
“The only defined targets of Rtp4 are opioid receptors (Decaillot et al., 2008)”
From Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens (2018) · cites this paper as Decaillot et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Allosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Exploring the opioid system by gene knockout
Kieffer, B. L., & Gavériaux-Ruff, C. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00008-4 · Cited by 620 · cited 1×
“opioid receptors mediate most of the pain-relieving effects of morphine, the prototypical analgesic used in clinics (11).”
BackgroundRTP Family Members Induce Functional Expression of Mammalian Odorant Receptors
Saito, H., Kubota, M., Roberts, R. W., Chi, Q., & Matsunami, H. (2004) · Cell · doi:10.1016/j.cell.2004.11.021 · Cited by 613
Bulenger, S., Marullo, S., & Bouvier, M. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.004 · Cited by 448
A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia
Gomes, I., Gupta, A., Filipovska, J., Szeto, H. H., Pintar, J. E., & Devi, L. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307601101 · Cited by 388
Self-citationA heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers
Waldhoer, M., Fong, J., Jones, R. M., Lunzer, M. M., Sharma, S. K., Kostenis, E., Portoghese, P. S., & Whistler, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501112102 · Cited by 347
Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting
Salahpour, A., Angers, S., Mercier, J.-F., Lagacé, M., Marullo, S., & Bouvier, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403363200 · Cited by 296
Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking
Devi, L. A. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01799-5 · Cited by 282
Self-citation
Cited by
Molecular mechanisms of opioid receptor-dependent signaling and behavior
Al-Hasani, R., & Bruchas, M. R. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318238bba6 · Cited by 1,067
Fine-tuning of GPCR activity by receptor-interacting proteins
Ritter, S. L., & Hall, R. A. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2803 · Cited by 480
CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration
Décaillot, F. M., Kazmi, M. A., Lin, Y., Ray-Saha, S., Sakmar, T. P., & Sachdev, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277038 · Cited by 333
Self-citationG protein-coupled receptor heteromers
Gomes, I., Ayoub, M. A., Fujita, W., Jaeger, W. C., Pfleger, K. D. G., & Devi, L. A. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135952 · Cited by 262
Self-citationIncreased Abundance of Opioid Receptor Heteromers After Chronic Morphine Administration
Gupta, A., Mulder, J., Gomes, I., Rozenfeld, R., Bushlin, I., Ong, E., Lim, M., Maillet, E., Junek, M., Cahill, C. M., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2000807 · Cited by 226
Self-citationDelta and Kappa Opioid Receptors as Suitable Drug Targets for Pain
Vanderah, T. W. (2010) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181c49e3a · Cited by 198
Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens
Wroblewska, A., Dhainaut, M., Ben-Zvi, B., Rose, S. A., Park, E. S., Amir, E.-A. D., Bektesevic, A., Baccarini, A., Merad, M., Rahman, A. H., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.022 · Cited by 168
Chaperoning G Protein-Coupled Receptors: From Cell Biology to Therapeutics
Tao, Y., & Conn, P. M. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1121 · Cited by 156
The role of dimerisation in the cellular trafficking of G-protein-coupled receptors
Milligan, G. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.09.010 · Cited by 149
Molecular Pharmacology of δ-Opioid Receptors
Gendron, L., Cahill, C. M., von Zastrow, M., Schiller, P. W., & Piñeyro, G. (2016) · Pharmacological Reviews · doi:10.1124/pr.114.008979 · Cited by 149
Receptor heteromerization and drug discovery
Rozenfeld, R., & Devi, L. A. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.008 · Cited by 130
Self-citationDelta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches
Gavériaux‐Ruff, C., & Kieffer, B. L. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32834a1f2c · Cited by 136
A Pluridimensional View of Biased Agonism
Costa-Neto, C. M., Parreiras‐e‐Silva, L. T., & Bouvier, M. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105940 · Cited by 123
Opioid-induced Cardioprotection
Tanaka, K., Kersten, J. R., & Riess, M. L. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140204120311 · Cited by 121
An update on the physiological and therapeutic relevance of GPCR oligomers
Farran, B. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.008 · Cited by 115
Opioid-receptor-heteromer-specific trafficking and pharmacology
van Rijn, R. M., Whistler, J. L., & Waldhoer, M. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.09.007 · Cited by 111
Heteromers of μ‐δ opioid receptors: new pharmacology and novel therapeutic possibilities
Fujita, W., Gomes, I., & Devi, L. A. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12663 · Cited by 98
Self-citationRecent advances on the δ opioid receptor: from trafficking to function
Gendron, L., Mittal, N., Beaudry, H., & Walwyn, W. M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12706 · Cited by 103
Sebag, J. A., & Hinkle, P. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022400 · Cited by 87
Fujita, W., Gomes, I., & Devi, L. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12798 · Cited by 97
Self-citationOpioid receptor heteromers in analgesia
Costantino, C. M., Gomes, I., Stockton, S. D., Lim, M. P., & Devi, L. A. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.5 · Cited by 95
Self-citationG Protein-Coupled Receptor Heteromerization: A Role in Allosteric Modulation of Ligand Binding
Gomes, I., IJzerman, A. P., Ye, K., Maillet, É. L., & Devi, L. A. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070847 · Cited by 93
Self-citationG Protein Activation by Serotonin Type 4 Receptor Dimers
Pellissier, L. P., Barthet, G., Gaven, F., Cassier, E., Trinquet, E., Pin, J.-P., Marin, P., Dumuis, A., Bockaert, J., Banères, J.-L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.201939 · Cited by 79
Beaudry, H., Dubois, D., & Gendron, L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1817-11.2011 · Cited by 90
Zhang, L., Zhang, J., Hang, L., & Liu, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01078 · Cited by 83
Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents
Tiwari, V., He, S.-Q., Huang, Q., Liang, L., Yang, F., Chen, Z., Tiwari, V., Fujita, W., Devi, L. A., Dong, X., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001768 · Cited by 82
Self-citationOligomerization of G-protein-coupled receptors: A reality
Ferré, S., & Franco, R. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.11.002 · Cited by 80
G protein-coupled receptor heteromers are key players in substance use disorder
Derouiche, L., & Massotte, D. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.026 · Cited by 77
Transcriptional and Epigenetic Regulation of Opioid Receptor Genes: Present and Future
Wei, L.-N., & Loh, H. H. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100605 · Cited by 72
GPCR-Interacting Proteins, Major Players of GPCR Function
Maurice, P., Guillaume, J., Benleulmi‐Chaachoua, A., Daulat, A. M., Kamal, M. T., & Jockers, R. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385952-5.00001-4 · Cited by 76
Boys, I. N., Xu, E., Mar, K. B., Cruz-Rivera, P. C. D. L., Eitson, J. L., Moon, B., & Schoggins, J. W. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.09.014 · Cited by 72
The role of δ‐opioid receptors in learning and memory underlying the development of addiction
Klenowski, P. M., Morgan, M., & Bartlett, S. E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12618 · Cited by 70
GPCR heteromers: An overview of their classification, function and physiological relevance
Dale, N. C., Johnstone, E. K. M., & Pfleger, K. D. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931573 · Cited by 70
Whole-Genome Linkage and Association Scan in Primary, Nonsyndromic Vesicoureteric Reflux
Cordell, H. J., Darlay, R., Charoen, P., Stewart, A., Gullett, A. M., Lambert, H. J., Malcolm, S., Feather, S. A., Goodship, T. H. J., Woolf, A. S., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060624 · Cited by 69
Strategies towards safer opioid analgesics—A review of old and upcoming targets
Varga, B. R., Streicher, J. M., & Majumdar, S. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15760 · Cited by 69
G Protein-Coupled Receptor Heteromers as New Targets for Drug Development
Ferré, S., Navarro, G., Casadó, V., Cortés, A., Mallol, J., Canela, E. I., Lluís, C., & Franco, R. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)91002-8 · Cited by 68
Post-translational Modifications of Opioid Receptors
Duarte, M. L., & Devi, L. A. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.03.011 · Cited by 66
Self-citationWu, L., Pan, Y., Chen, G., Matsunami, H., & Zhuang, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.345884 · Cited by 65
Milan‐Lobo, L., & Whistler, J. L. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179093 · Cited by 63
Enhancement of the surface expression of G protein-coupled receptors
Dunham, J. H., & Hall, R. A. (2009) · Trends in biotechnology · doi:10.1016/j.tibtech.2009.06.005 · Cited by 63
G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)
Ferré, S., Ciruela, F., DESSAUER, C. W., González‐Maeso, J., Hébert, T. E., Jockers, R., Logothetis, D. E., & Pardo, L. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107977 · Cited by 61
Bruno, A., Guadix, A. E., & Costantino, G. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900067g · Cited by 58
Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain
Podolsky, A. T., Sandweiss, A. J., Hu, J., Bilsky, E. J., Cain, J. P., Kumirov, V. K., Lee, Y. S., Hruby, V. J., Vardanyan, R., & Vanderah, T. W. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.09.016 · Cited by 58
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
He, X., Ashbrook, A. W., Du, Y., Wu, J., Hoffmann, H.-H., Zhang, C., Xia, L., Peng, Y., Tumas, K. C., Singh, B. K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006492117 · Cited by 57
Маслов, Л. Н., Naryzhnaya, N. V., Tsibulnikov, S. Y., Kolář, F., Zhang, Y., Wang, H., Гусакова, А. М., & IuB, L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.07.018 · Cited by 57
Golebiewska, U. P., Johnston, J. M., Devi, L. A., Filizola, M., & Scarlata, S. (2011) · Biochemistry · doi:10.1021/bi101701x · Cited by 56
Self-citationRecent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics
Remesic, M., Hruby, V. J., Porreca, F., & Lee, Y. S. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00090 · Cited by 52
In vivoopioid receptor heteromerization: where do we stand?
Massotte, D. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12702 · Cited by 50
Olson, K. M., Keresztes, A. I., Tashiro, J., Daconta, L. V., Hruby, V. J., & Streicher, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00403 · Cited by 50
Endogenous opiates and behavior: 2008
Bodnar, R. J. (2009) · Peptides · doi:10.1016/j.peptides.2009.09.027 · Cited by 49
Guidolin, D., Marcoli, M., Tortorella, C., Maura, G., & Agnati, L. F. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0087 · Cited by 46
Transcriptome Sequencing of Gene Expression in the Brain of the HIV-1 Transgenic Rat
Li, M. D., Cao, J., Wang, S., Wang, J., Sarkar, S., Vigorito, M., Ma, J. Z., & Chang, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059582 · Cited by 45
Stockton, S. D., & Devi, L. A. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.10.025 · Cited by 44
Self-citationWalwyn, W. M., John, S., Maga, M., Evans, C. J., & Hales, T. G. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055913 · Cited by 42
Oligomerization of GPCRs involved in endocrine regulation
Kleinau, G., Müller, A., & Biebermann, H. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0049 · Cited by 42
Malik, S., Dolan, T. M., Maben, Z. J., & Hinkle, P. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.668491 · Cited by 41
Analgesia and central side‐effects: two separate dimensions of morphine response
Droney, J., Gretton, S. K., Sato, H., Ross, J. R., Branford, R., Welsh, K. I., Cookson, W., & Riley, J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12008 · Cited by 40
G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes
Roux, B. T., & Cottrell, G. S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011112 · Cited by 40
Shiwarski, D. J., Crilly, S. E., Dates, A. N., & Puthenveedu, M. A. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-05-0292 · Cited by 40
Mechanisms of selective G protein–coupled receptor localization and trafficking
Kunselman, J. M., Lott, J., & Puthenveedu, M. A. (2021) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2021.03.002 · Cited by 38
Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors
Ong, E. W., & Cahill, C. M. (2014) · Cells · doi:10.3390/cells3010152 · Cited by 37
The role of G-proteins in the dimerisation of human somatostatin receptor types 2 and 5
Grant, M. P., & Kumar, U. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.08.011 · Cited by 34
Keresztes, A. I., Olson, K. M., Nguyen, P., Lopez‐Pier, M. A., Hecksel, R., Barker, N. K., Liu, Z., Hruby, V. J., Konhilas, J. P., Langlais, P. R., et al. (2021) · Pain · doi:10.1097/j.pain.0000000000002320 · Cited by 34
Faouzi, A., Uprety, R., Gomes, I., Massaly, N., Keresztes, A. I., Rouzic, V. L., Gupta, A., Zhang, T., Yoon, H. J., Ansonoff, M. A., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00901 · Cited by 33
Self-citationGentzsch, C., Seier, K., Drakopoulos, A., Jobin, M., Lanoiselée, Y., Kőszegi, Z., Maurel, D., Sounier, R., Hübner, H., Gmeiner, P., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201912683 · Cited by 33
Ramp Like Proteins: RTP and REEP Family of Proteins
Mainland, J. D., & Matsunami, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-2364-5_7 · Cited by 31
A G protein–coupled receptor and the intracellular synthase of its agonist functionally cooperate
Binda, C., Génier, S., Cartier, A., Larrivée, J., Staňková, J., Young, J. C., & Parent, J. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201304015 · Cited by 30
St‐Louis, E., Degrandmaison, J., Grastilleur, S., Génier, S., Blais, V., Lavoie, C. L., Parent, J., & Gendron, L. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.12.005 · Cited by 30
Bono, F., Mutti, V., Devoto, P., Bolognin, S., Schwamborn, J. C., Missale, C., & Fiorentini, C. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.12.001 · Cited by 29
Alterations of CXCR4 function in μ‐opioid receptor‐deficient glia
Burbassi, S., Sengupta, R., & Meucci, O. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07402.x · Cited by 28
Rogacki, M. K., Golfetto, O., Tobin, S. J., Li, T., Biswas, S., Jorand, R., Zhang, H., Radoi, V., Yu, M., Svenningsson, P., et al. (2018) · Traffic · doi:10.1111/tra.12582 · Cited by 28
He, X. J., Patel, J., Weiss, C. E., Ma, X., Bloodgood, B. L., & Banghart, M. R. (2021) · eLife · doi:10.7554/elife.69746 · Cited by 28
Regulation of an Opioid Receptor Chaperone Protein, RTP4, by Morphine
Fujita, W., Yokote, M., Gomes, I., Gupta, A., Ueda, H., & Devi, L. A. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.112987 · Cited by 27
Self-citationProlonged morphine treatment alters δ opioid receptor post‐internalization trafficking
Ong, E. W., Xue, L., Olmstead, M. C., & Cahill, C. M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12761 · Cited by 26
Mu and Delta Opioid Receptors Diverge
Woolf, C. J. (2009) · Cell · doi:10.1016/j.cell.2009.05.033 · Cited by 26
Haddad, A., Flint-Ashtamker, G., Minzel, W., Sood, R., Rimon, G., & Barki‐Harrington, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304220 · Cited by 26
Fukutani, Y., Tamaki, R., Inoue, R., Koshizawa, T., Sakashita, S., Ikegami, K., Ohsawa, I., Matsunami, H., & Yohda, M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007110 · Cited by 25
Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities
Gaborit, M., & Massotte, D. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15772 · Cited by 25
Kuang, Y., Charette, N., Frazer, J., Holland, P., Attwood, K. M., Dellaire, G., & Dupré, D. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040522 · Cited by 24
Ferré, S., Lluís, C., Lanciego, J. L., & Franco, R. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793361603 · Cited by 24
Simultaneous targeting of multiple opioid receptor types
Bird, M. F., & Lambert, D. G. (2015) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000129 · Cited by 24
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits
Davis, M. P. (2025) · Drugs · doi:10.1007/s40265-024-02128-y · Cited by 21
Charette, N., Holland, P., Frazer, J., Allen, H., & Dupré, D. J. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.008 · Cited by 21
Shenoy, S. K. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-41199-1_10 · Cited by 22
Class A and C GPCR Dimers in Neurodegenerative Diseases
Moreira, I. S., Caniceiro, A. B., Bueschbell, B., & Schiedel, A. C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220327221830 · Cited by 20
Martinez‐Fernandez, A., Li, X., Hartjes, K. A., Terzic, A., & Nelson, T. J. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000045 · Cited by 19
MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligands
Bird, M. F., McDonald, J., Horley, B., O’Doherty, J. P., Fraser, B., Gibson, C. L., Guerrini, R., Calò, G., & Lambert, D. G. (2022) · PLoS ONE · doi:10.1371/journal.pone.0260880 · Cited by 19
GPCR Oligomerization: Contribution to Receptor Biogenesis
Van Craenenbroeck, K. (2012) · Subcellular Biochemistry · doi:10.1007/978-94-007-4765-4_3 · Cited by 18
Yu, T., Su, X., Pan, Y., & Zhuang, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179067 · Cited by 18
Gomes, I., Gupta, A., & Devi, L. A. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391862-8.00012-0 · Cited by 17
Self-citationIntlekofer, K. A., Clements, K. J., Woods, H. C., Adams, H., Suvorov, A., & Petersen, S. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215389 · Cited by 17
Norheim, K. B., Imgenberg‐Kreuz, J., Alexsson, A., Johnsen, S. J. A., Bårdsen, K., Brun, J. G., Kiani, R., Theander, E., Mandl, T., Jonsson, R., et al. (2021) · RMD Open · doi:10.1136/rmdopen-2021-001832 · Cited by 15
Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4)
Kaur, R., Tada, T., & Landau, N. R. (2023) · mBio · doi:10.1128/mbio.01090-23 · Cited by 15
Williams, D., & Devi, L. A. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)91005-3 · Cited by 15
Self-citationAccelerator or Brake: Immune Regulators in Malaria
Cai, C., Hu, Z., & Yu, X. H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.610121 · Cited by 14
Bakare, T. T., Uzoeto, H. O., Gonlepa, L. N., Cosmas, S., Ajima, J. N., Arazu, A. V., Ezechukwu, S. P., Didiugwu, C. M., Ibiang, G. O., Osotuyi, A. G., et al. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03207-1 · Cited by 14
Zhao, X., Perez‐Aguilar, J. M., Matsunaga, F., Lerner, M., Jin, X., Selling, B. H., Johnson, A. T. C., Saven, J. G., & Liu, R. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000308 · Cited by 14
Gomes, I., Gupta, A., Bushlin, I., & Devi, L. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00268 · Cited by 14
Self-citationParker, M. S., Park, E. A., Sallee, F. R., & Parker, S. L. (2010) · Amino Acids · doi:10.1007/s00726-010-0616-1 · Cited by 14
Role of Chaperones in G Protein Coupled Receptor Signaling Complex Assembly
Dupré, D. J., Hammad, M. M., Holland, P., & Wertman, J. N. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-4765-4_2 · Cited by 13
Metadata
- Authors
- Décaillot, F. M., Rozenfeld, R., Gupta, A., & Devi, L. A.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY 10029
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-10-14
- Volume
- 105
- Issue
- 41
- Pages
- 16045-16050
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2572960
- OpenAlex
- W2086196752
- Cited by
- 152
- References
- 38
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 9 · 2019: 10 · 2018: 7 · 2017: 3 · 2016: 4 · 2015: 7 · 2014: 14 · 2013: 9 · 2012: 9
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA 08863, R56DA008863, R37DA008863, DA19251, R01DA008863)
- National Cancer Institute (R24CA095823)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- mu-opioid receptor, delta opioid receptor, receptor heterodimers, cell surface targeting, ubiquitination, receptor degradation, receptor dimerization
- MeSH terms
- Animals, Cell Line, Humans, Receptors, Opioid, mu, Receptors, Opioid, delta, Molecular Chaperones, Dimerization, Membrane Transport Proteins, Mice, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.